Electrical stimulation of C2C12 myotubes induces contractions and represses thyroid-hormone-dependent transcription of the fast-type sarcoplasmic reticulum Ca2+-ATPase gene by Thelen, M.H.M. et al.
Biochem. J. (1997) 321, 845–848 (Printed in Great Britain) 845
Electrical stimulation of C2C12 myotubes induces contractions and
represses thyroid-hormone-dependent transcription of the fast-type
sarcoplasmic-reticulum Ca2+-ATPase gene
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Chronic low-frequency contraction of skeletal muscle, either
induced by a slow motor nerve or through direct electrical
stimulation, generally induces expression of proteins associated
with the slow phenotype, while repressing the corresponding fast
isoforms. Contractions thereby counteract the primarily trans-
criptional effect of thyroid hormone (T
$
), which results in the
selective induction and stimulation of expression of fast isoforms.
We studied the regulation of expression of the fast-type sarco-
plasmic-reticulum Ca#+-ATPase (SERCA1), a characteristic
component of the fast phenotype. Previous work suggested that
reduction of SERCA1 expression by contractile activity might
result from interference with the T
$
-dependent transcriptional
INTRODUCTION
Most skeletal muscles have a mixed composition of slow and fast
fibres. The phenotype of these fibres is characterized by their
metabolic rate and the isoforms of the muscle genes they express.
The phenotype of skeletal-muscle fibres in the rat is primarily
determined by the type of innervation and the thyroid status.
Prolonged low-frequency contractile activity imposed by a slow
motor nerve stimulates expression of muscle proteins associated
with the slow phenotype and represses expression of proteins
associated with the fast phenotype [1–4]. It is now known that it
is not the nerve itself but the activity induced by it that triggers
this shift in phenotype [1,5,6]. Thyroid hormone (T
$
), on the
other hand, stimulates expression of proteins associated with the
fast phenotype at the expense of their slow counterparts [7,8]. We
studied the expression of the fast-type skeletal-muscle sarco-
plasmic-reticulum Ca#+-ATPase (SERCA1), the induction of
which is dependent on T
$
[9–11], and we have shown that, in rat
soleus muscle, T
$
co-ordinately replaces slow isoforms of myosin
heavy chain and sarcoplasmic reticulum Ca#+-ATPase with fast
isoforms [12,13]. The stimulation of SERCA1 expression by T
$
is
brought about by an increase in the transcription frequency of
the SERCA1 gene [14], mediated by thyroid-hormone-response
elements in the promoter of the gene [15], as has also been shown
for other genes up-regulated by T
$
(reviewed in [16,17]).
How contractile activity exerts its effect on muscle phenotype
is unknown, but a mediating role for the free cytosolic Ca#+
concentration ([Ca#+]
i
), which increases with contraction, has
been suggested [18]. We found in rat L6 myotubes that T
$
-
Abbreviations used: AraC, 1-(b-D-arabinofuranosyl)cytosine ; DMEM, Dulbecco’s modified Eagle’s medium; SERCA1, fast-type sarcoplasmic-
reticulum Ca2+-ATPAse; T3, L-tri-iodothyronine (thyroid hormone) ; FCS, fetal calf serum; TxFCS, thyroid-hormone-depleted FCS; CAT, chloramphenicol
acetyltransferase ; [Ca2+]i, free cytosolic Ca
2+ concentration.
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stimulation of the SERCA1 gene. The present study was set up
to test this unexpected mode of action of contractile activity. We
show that electrical stimulation of C2C12 mouse myotubes,
which results in synchronous contractions at the imposed fre-
quency, reduces basal but virtually abolishes T
$
-dependent
SERCA1 expression. T
$
-dependent expression of a reporter gene
driven by the SERCA1 promoter was similarly affected by
electrical stimulation. This is the first demonstration that the
counteracting effects on muscle gene expression of electrically
induced contractions and T
$
may interact at the transcriptional
level.
dependent SERCA1 expression in particular was greatly reduced
when [Ca#+]
i
was increased above the resting level of 120 nM [19].
However, increased steady-state [Ca#+]
i
in these non-contracting
cells is not the same as an increase in the average [Ca#+]
i
as a
result of continuous repetitive contraction. Therefore we have
developed an in itro system that allows direct determination of
the effects of contractions and T
$
on muscle gene expression,
without the disturbing influence of secondary effects of altered
innervation inherent in io. We used mouse C2C12 muscle cells,
which, unlike L6 cells, can be induced to contract by direct
electrical stimulation, and determined the effect of T
$
and
contractile activity on SERCA1 expression and SERCA1 pro-
moter activity. We demonstrate specific interaction between
electrically induced contractile activity and transcriptional stimu-
lation by T
$
.
MATERIALS AND METHODS
Materials
For electrical stimulation of C2C12 myotubes we used custom-
built electrodes which were made of 1 mm platinum wire inte-
grated into lids of six-well dishes (well diameter 36 mm). For
each well two half-circle electrodes were aligned to the side of the
well in order to obtain a maximal area of stimulation.
Fetal calf serum (FCS) and Dulbecco’s modified Eagle’s
medium (DMEM) were obtained from Gibco–BRL (Paisley,
Scotland, U.K.) and insulin (bovine) was from Serva (Heidelberg,
Germany). 1-(b-d-Arabinofuranosyl)cytosine (AraC) and T
$
were obtained from Sigma (St. Louis, MO, U.S.A.). Culture
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plastics were from Nunc (Roskilde, Denmark). AG-1-X8 anion-
exchange resin was from Bio-Rad (Richmond, CA, U.S.A.).
[$H]Chloramphenicol was from Du Pont–New England Nuclear
(Wilmington, DE, U.S.A.) and all DNA-modification enzymes
were obtained from Boehringer-Mannheim (Mannheim,
Germany). The b-galactosidase determination kit was from
Promega (Madison, WI, U.S.A.).
Cell culture and electrical stimulation
C2C12 cells were grown to confluence in 0±1% gelatin-coated
six-well multidishes in DMEM containing 10% (v}v) FCS
depleted of thyroid hormones (TxFCS) by AG-1-X8 resin
treatment [20]. At day 0 differentiation was induced by lowering
the serum concentration to 2±5% (v}v) as described by Carnac et
al. [21]. To stimulate the fusion and differentiation process this
‘differentiation medium’ was supplemented with insulin
(1 lg}ml) [22]. Cultures were divided into three groups: one
group received 100 nM T
$
from day 0, one group received T
$
from day 3, and one group received no T
$
. At 2 days after the
switch to differentiation medium, AraC (4 lg}ml) was added to
the medium to eliminate any proliferating cells (myoblasts) [11].
The medium was then changed every 24 h. Starting from day 3,
when fusion was complete, cells were stimulated to contract
using 6 ms pulses of 3 V}cm#, at 2 Hz. Cells were harvested at
day 3 (when electrical stimulations were started) and at day 5.
SERCA1 protein analysis
For the determination of total protein and SERCA1 protein
levels, cultures were washed twice with PBS and then covered
with 300 ll of PBS and frozen at ®20 °C. After thawing, the cells
were harvested by scraping with a rubber ‘policeman’ and stored
at ®20 °C. SERCA1 protein levels were determined by ELISA
as described by Muller et al. [11] using the SERCA1-specific
antibody A52, which was a gift from Dr. MacLennan (Banting
and Best Institute, Toronto, Ontario, Canada). SERCA1 levels
were expressed relative to total protein as determined by the
method of Lowry et al. [23].
Transient transfections and expression assay
Expression constructs of the rat SERCA1 promoter driving the
chloramphenicol acetyltransferase (CAT) gene were made by
subcloning deletion constructs of the previously described [15]
SERCA1 gene 5« flanking sequence with 5« ends at ®2658 or
®141 and a common 3« end at ­91 (­1 is the transcription-
initiation site) into the pOCAT2 chloramphenicol [24] expression
vector. Part of the 5« flanking sequence of the rat SERCA1 gene
has been submitted to the EMBL, GenBank and DDBJ
Nucleotide Sequence Databases under the accession number
U34282.
C2C12 myoblasts were seeded at 22¬10$ cells}cm# on 0±1%
gelatin-coated six-well multidishes. The next day, when cultures
were 70–80% confluent, cells were transiently transfected using
the calcium phosphate precipitation method [25]. Together with
the SERCA1}pOCAT construct we co-transfected the construct
pCDM13, which expresses the thyroid hormone receptor a1
[kindly provided by Dr. G. A. Brent (Brigham and Women’s
Hospital, Boston, MA, U.S.A.)] as described by Prost et al. [26].
Cells were also co-transfected with a construct in which the b-
galactosidase gene was driven by the cytomegalovirus promoter
(pCMV-b-Gal) to allow correction for differences in transfection
efficiency between wells. Transfection mixes were prepared for 12
wells (two six-well dishes) and contained per well : 2 lg of
SERCA1}CATconstruct, 0±3 lg of pCDM13and 1 lg of pCMV-
b-Gal. The next day (day 0) cells were washed twice with PBS
and once with DMEM containing 5% TxFCS after which cells
were switched to differentiation medium [DMEM with 2±5%
TxFCS, insulin (1 lg}ml)]. At day 2, AraC (4 lg}ml) was added
to the medium, which was changed every 24 h from then on. At
day 3, T
$
treatment (50 nM) and electrical stimulations were
started. Of the sets of two dishes that received the same
transfection mixture, one dish was stimulated and the other
served as a control. At day 5, cultures were harvested and
analysed for CAT activity by the phase-extraction method
(overnight incubations at 37 °C) [27] and normalized to b-
galactosidase activity, which was assayed according to the
manufacturer’s protocol. Transfections with the promoterless
pOCAT2 vector served as a control for non-specific effects of T
$
or electrical stimulation on CAT activity. Parallel cultures were
used for the determination of the transfection efficiency, which
was at least 10% as determined by in situ b-galactosidase activity
assay [28].
Statistics
Data are displayed as means³S.E.M. for n experiments and
were evaluated by two-sided Student’s t test. Data for individual
experiments were obtained from duplicate (SERCA1 protein
level) or triplicate (transfections) cell cultures. Differences were
considered significant at P! 0±05.
RESULTS
Effect of T3 on SERCA1 expression in C2C12 cells
To determine the optimal time points for the assessment of the
effect of contractions on basal and T
$
-induced SERCA1 ex-
pression in C2C12 cells, we performed an experiment to establish
the time course of the expression of SERCA1 and its stimulation
by T
$
in these cells. Fusion, which was complete at day 3, and
myotube morphology were not affected by T
$
treatment. Figure
1 shows that basal as well as T
$
-induced expression increased
gradually to reach a maximal level at day 5. Beyond this time
point the quality of the cultures started to deteriorate.
Figure 1 Effect of T3 on SERCA1 expression in C2C12 myotubes
Cells were grown as described in the Materials and methods section in the absence (D) or
presence (E) of T3. Data points represent means³S.D. of a representative experiment in
duplicate.
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Table 1 Effect of contractile activity on the expression of SERCA1 protein
Cells were grown and SERCA1 protein expression was determined as described in the Materials
and methods section. Differentiation was induced at day 0 and electrical stimulations were
started at day 3. T3 treatment was started at either day 0 or day 3. Data for individual
experiments were normalized to the value found in quiescent controls at day 5 and are presented
as percentage of the SERCA1 protein level at day 3. Data represent means³S.E.M. for three
experiments. *P ! 0±05 for T3 versus control ; P ! 0±05 for contractions versus no
contractions.
Day 5
Day 3 No contractions Contractions
No T3 100³31 197 97³8±7
T3 from day 3 – 278³18±3* 102³9±7
T3 from day 0 139³33±1* 500³93±7* 147³8±8*
Electrical stimulation of C2C12 myotubes
Electrical stimulation of C2C12 myotubes with 6 ms pulses of
3 V}cm# resulted in synchronous contractions at the frequency of
pacing (2 Hz), and this was maintained for 48 h in at least 70%
of the myotubes. Variation of this voltage or pulse duration either
compromised participation or the period over which contractions
followed the stimulation frequency. In cultures that were not
electrically stimulated, no contractions were observed. Contrac-
tions, in either the presence or absence of T
$
, did not affect
myotube morphology and no signs of cell death were observed in
any group. Coating of the culture surface with a 0±1% gelatin
solution was found to be necessary to prevent detachment of
contracting cells. In non-stimulated cultures grown in the pres-
ence of T
$
, the protein content decreased slightly between day 3
and day 5 resulting in a small but significant difference from the
T
$
-treated contracting cultures (®16³3%, n¯ 3, P! 0±05).
Effect of electrical stimulation on SERCA1 expression
Starting from day 3, when fusion was complete, C2C12 myotubes
were stimulated to contract at 2 Hz and were given T
$
. Table 1
shows that contractions completely abolished T
$
stimulation of
SERCA1 expression, which at day 5 amounted to 1±4³0±1-fold
(n¯ 3, P! 0±05) in quiescent cells. The basal level of expression
of SERCA1 in contracting cells was reduced compared with
quiescent cells by 50³5% (n¯ 3, P! 0±05) at day 5.
Because of the general stimulatory effect of T
$
on muscle cell
differentiation [29], we also studied the effect of contractions in
cultures in which T
$
treatment was started, together with the
Table 2 Effect of contractile activity on T3 induction of SERCA1 promoter activity
C2C12 myoblasts were transfected with pOCAT constructs containing 5« flanking sequence of the SERCA1 gene. The SERCA1 inserts had a common 3« end at ­91. The 5« end of the construct
is indicated by the name of the construct. Cell culture and transfections were performed as described in the Materials and methods section. CAT activities were normalized to b-galatosidase activity
which was unaffected by contractile activity. Data are presented as percentage of the normalized CAT activity found in quiescent cultures without addition of T3 and represent the means³S.E.M.
for four (three for the promoterless pOCAT2) experiments. *P ! 0±05 for T3 versus control ; P ! 0±05 for contractions versus no contractions. Promoter activity of the ®141 and ®2658 fragment
resulted in a stimulation of basal CAT expression of 10-fold and 40-fold relative to the pOCAT2 vector respectively.
®T3 ­T3 T3 induction ratio
Contractions… ® ­ ® ­ ® ­
pOCAT2/®2658 100 118³31 700³57* 296³119 7±0³0±6 * 2±5³1±0
pOCAT2/®141 100 94³7 104³4 97³18 1±0³0±1 1±0³0±1
pOCAT2 100 86³17 101³18 86³5 1±0³0±2 1±0³0±1
induction of differentiation (day 0), 2 days before the onset of
electrical stimulation. This protocol allowed undisturbed de-
velopment of factors possibly involved in T
$
stimulation that
might otherwise be inhibited by contractions between day 3 and
day 5. At day 3, when contractions were started, the T
$
stimulation of SERCA1 expression was 1±4³0±1-fold (n¯ 3,
P! 0±05). Over the period between day 3 and day 5, the fold T
$
stimulation of SERCA1 expression in quiescent cells increased to
2±5³0±2 (n¯ 3, P! 0±05). In contracting cells, however, the T
$
stimulation of SERCA1 expression did not increase further,
remaining at 1±5³0±1 at day 5 (n¯ 3, P! 0±05).
Effect of electrical stimulation on SERCA 1 promoter activity
Whereas contractions reduced basal SERCA1 expression, they
abolished its stimulation by T
$
. The fact that T
$
mediates its
effect on SERCA1 expression at the transcriptional level [14,15]
suggests that contractile activity interferes with the effect of T
$
at
that level. To study the effect of contractions on SERCA1
promoter activity and its stimulation by T
$
we have developed a
system that allows electrical stimulation in transiently transfected
cells. C2C12myoblasts were transfected with pOCAT2 constructs
containing the CAT reporter gene driven by SERCA1 promoter
fragments. After transfection, these myoblasts were allowed to
fuse and differentiate into myotubes in which contractions were
induced by electrical stimulation. It was found that cultures
needed to be thoroughly washed after transfection, as described
in the Materials and methods section, to allow normal fusion and
contractile activity in response to electrical stimulation. As in
control cultures, contractions could be maintained for 48 h in
transfected cells and despite the relatively long period between
transfection and harvesting of the cells, the expression of the
pOCAT2}SERCA1 constructs did not deteriorate (not shown).
Furthermore contractions had no effect on b-galactosidase
expression from the co-transfected CMV-Gal plasmid used for
normalization.
Table 2 summarizes the results of the transfection study. Cells
transfected with pOCAT2}®2658, containing 2658 nucleotides
of the SERCA1 5« flanking sequence, showed a 7±0³0±6-fold
(n¯ 4, P! 0±05) stimulation of normalized CAT activity by T
$
in quiescent cells. Contractions significantly reduced this stimu-
lation to 2±5³1±0-fold (n¯ 4, P! 0±05). The basal activity of
this construct was not significantly altered by contractile activity.
When the SERCA1 5« sequence was truncated to ®141, leaving
a minimal functional promoter, T
$
and contractions no longer
affected transcription. Also in transfections with the promoterless
pOCAT2 expression vector, CAT activity was independent of T
$
or contractile activity. This implies that the observed reduction
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in T
$
stimulation of CAT activity in experiments with pOCAT}
®2658 is not due to a general non-specific effect of contractions,
but results from an almost complete inhibition of T
$
stimulation
of SERCA1 promoter activity.
DISCUSSION
In agreement with results for skeletal muscle in io and the
skeletal-muscle cell line L6, T
$
markedly increased SERCA1
expression in C2C12 cells. Electrical stimulation of C2C12
myotubes, resulting in synchronous contractions at the imposed
frequency (2 Hz), repressed basal but abolished T
$
-dependent
SERCA1 expression. Since this effect also occurred in cells that
were allowed to grow in the presence of T
$
before contractions
were started, we conclude that contractions inhibit the T
$
stimulation of SERCA1 expression rather than processes
responsible for the development of this effect, such as the pro-
duction of thyroid hormone receptor or cofactors that participate
in the transcriptional activation by thyroid hormone receptor.
We have previously shown that T
$
stimulates the expression of
SERCA1 by increasing the activity of the SERCA1 promoter
[14,15]. Analysis of SERCA1-promoter activity in C2C12 cells
revealed a reduction in T
$
stimulation from 7-fold in non-
contracting cells to a no longer significant 2±5-fold stimulation in
contracting cells. This effect of contractions was promoter-
specific, and depended on sequences upstream of position ®141
relative to the transcription-initiation site. This strongly suggests
that the repression of the T
$
-dependent SERCA1 expression by
contractions is at least in part a result of decreased transcription
frequency of the SERCA1 gene, rather than altered stability of
SERCA1 protein or the mRNA coding for it. The repression of
basal SERCA1 protein expression by contractions did not appear
to result from an effect on transcription driven by the first
2658 bp of the SERCA1 5« flanking sequence. However, it
cannot be excluded that further upstream sequences are involved
in such regulation. Alternatively post-transcriptional events may
be involved.
Although effects of electrical stimulation not related to con-
traction cannot be excluded, the findings of the present study
provide a mechanism of interaction by which the opposing
stimuli of T
$
and (chronic) contractile activity determine the
expression of SERCA1, a typical fast isoform, in skeletal muscle.
Previous work had already indicated that the proportion of fast
isoforms in skeletal-muscle fibres is determined by the balance
between the stimulating effect of T
$
and the inhibiting effect of
the so-called slow-type contractile activity [1–4,7,8,12,13,30].
The co-ordinated regulation of several phenotype-specific
Received 7 August 1996/30 September 1996 ; accepted 1 October 1996
proteins, such as SERCA and myosin heavy and light chain
isoforms [1,4,12,13,30], suggests that the mechanism of inter-
action described may apply to other muscle proteins as well.
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